Aquestive Therapeutics Inc (AQST)
3.23
-0.14
(-4.01%)
USD |
NASDAQ |
May 02, 14:06
Aquestive Therapeutics Total Assets (Quarterly): 57.42M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 57.42M |
| September 30, 2023 | 59.45M |
| June 30, 2023 | 56.99M |
| March 31, 2023 | 61.28M |
| December 31, 2022 | 57.07M |
| September 30, 2022 | 51.84M |
| June 30, 2022 | 56.31M |
| March 31, 2022 | 56.53M |
| December 31, 2021 | 61.99M |
| September 30, 2021 | 65.29M |
| June 30, 2021 | 66.88M |
| March 31, 2021 | 61.92M |
| December 31, 2020 | 62.88M |
| Date | Value |
|---|---|
| September 30, 2020 | 50.42M |
| June 30, 2020 | 63.55M |
| March 31, 2020 | 64.49M |
| December 31, 2019 | 78.48M |
| September 30, 2019 | 48.82M |
| June 30, 2019 | 50.41M |
| March 31, 2019 | 67.98M |
| December 31, 2018 | 86.85M |
| September 30, 2018 | 90.01M |
| June 30, 2018 | 39.84M |
| March 31, 2018 | 46.08M |
| December 31, 2017 | 43.12M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
48.82M
Minimum
Sep 2019
78.48M
Maximum
Dec 2019
59.58M
Average
59.45M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Lifecore Biomedical Inc | 255.15M |
| Harrow Inc | 312.16M |
| Akebia Therapeutics Inc | 241.70M |
| 89bio Inc | 596.27M |
| Geron Corp | 394.08M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 163.90M |
| Shareholders Equity (Quarterly) | -106.49M |
| Debt to Equity Ratio | -0.2585 |
| Current Ratio | 2.238 |
| Net Debt Paydown Yield | 3.67% |